top of page
Search


Praxis FDA Clinical Trial Phase 3 - Upcoming Interim Results Q1 2025
Executive Summary - Praxis is a short going into interim results. Praxis Precision Medicines is developing Ulixacaltamide, a small...
Apr 158 min read
bottom of page